MY194653A - Novel immunotherapy against several tumors, such as lung cancer, including nsclc - Google Patents

Novel immunotherapy against several tumors, such as lung cancer, including nsclc

Info

Publication number
MY194653A
MY194653A MYPI2019007418A MYPI2019007418A MY194653A MY 194653 A MY194653 A MY 194653A MY PI2019007418 A MYPI2019007418 A MY PI2019007418A MY PI2019007418 A MYPI2019007418 A MY PI2019007418A MY 194653 A MY194653 A MY 194653A
Authority
MY
Malaysia
Prior art keywords
present
tumor
relates
lung cancer
against several
Prior art date
Application number
MYPI2019007418A
Inventor
Steffen Walter
Colette Song
Jens Fritsche
Toni Weinschenk
Harpreet Singh
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Priority to MYPI2019007418A priority Critical patent/MY194653A/en
Publication of MY194653A publication Critical patent/MY194653A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor- associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to more than 70 novel peptide sequences and their variants derived from HLA class I and HLA class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
MYPI2019007418A 2015-11-24 2015-11-24 Novel immunotherapy against several tumors, such as lung cancer, including nsclc MY194653A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2019007418A MY194653A (en) 2015-11-24 2015-11-24 Novel immunotherapy against several tumors, such as lung cancer, including nsclc

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2019007418A MY194653A (en) 2015-11-24 2015-11-24 Novel immunotherapy against several tumors, such as lung cancer, including nsclc

Publications (1)

Publication Number Publication Date
MY194653A true MY194653A (en) 2022-12-10

Family

ID=84926311

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2019007418A MY194653A (en) 2015-11-24 2015-11-24 Novel immunotherapy against several tumors, such as lung cancer, including nsclc

Country Status (1)

Country Link
MY (1) MY194653A (en)

Similar Documents

Publication Publication Date Title
PH12015502638A1 (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
PH12019502194A1 (en) Novel immunotherapy against several tumors including gastrointestinal and gastric cancer
PH12021551208A1 (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
MA39907A (en) Novel immunotherapy against several tumors of the blood, such as acute myeloid leukemia (aml)
EP3708185A3 (en) Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (cll)
MX2016005866A (en) Personalized immunotherapy against several neuronal and brain tumors.
MX338294B (en) Novel immunotherapy against several tumors including neuronal and brain tumors.
MX2010001086A (en) Novel immunotherapy against neuronal and brain tumors.
MX2019013163A (en) Novel immunotherapy against several tumors of the blood, such as acute myeloid leukemia (aml).
MY194653A (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
MY193910A (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
MY194244A (en) Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including Nsclc
MY194241A (en) Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including NSCLC
EA202090822A2 (en) A NEW METHOD FOR IMMUNOTHERAPY OF SEVERAL TUMORS OF TUMORS SUCH AS LUNG CANCER, INCLUDING NSCLC
MX2019013161A (en) Personalized immunotherapy against several neuronal and brain tumors.